Patient preference for triptan formulations: A prospective study with zolmitriptan

Headache

Volumn 47, Issue 8, 2007, Pages 1144-1151

  Dowson, Andrew ^a   Bundy, Michael ^b   Salt, Rebecca ^c   Kilminster, Shaun ^d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Cranleigh Health Centre   (United Kingdom)

^c Merrow Park Surgery   (United Kingdom)

^d INSTITUTE OF NAVAL MEDICINE   (United Kingdom)

Author keywords

Acute treatment; Migraine; Patient preference; Primary care; Zolmitriptan

Indexed keywords

ZOLMITRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DIZZINESS; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG PREFERENCE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; FATIGUE; FEMALE; HEAT SENSATION; HEAVINESS; HUMAN; MALE; MIGRAINE; MIGRAINE DISABILITY ASSESSMENT SCORE; MOUTH SWELLING; NAUSEA; PRESSURE SENSATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SKIN TINGLING; SORE THROAT; STIFF NECK; TABLET; TACHYCARDIA; TASTE DISORDER; THORAX DISEASE; THROAT CONSTRICTION; UNSPECIFIED SIDE EFFECT; VOMITING; WEAKNESS; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; PATIENT SATISFACTION; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX; TRYPTAMINES;

EID: 34648818989     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00805.x     Document Type: Article

References (19)

1. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet. 2001 358:1668-1675.
2. Dowson AJ, Kilminster S, Peters M, et al Understanding the evidence: Evaluating the efficacy of migraine medications in clinical practice. Headache Care. 2005 2:133 143.
3. Dowson AJ, Tepper SJ, Dahlöf C. Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine. J Headache Pain. 2005 6:112 120.
4. Stewart WF, Lipton RB, Whyte J, et al An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999 53:988 994.
5. Stewart WF, Lipton RB, Kolodner KB, et al Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000 88:41 52.
6. Otsuka N, Sakai F, Iigaya M, Igarashi H, Shirataka M. MIDAS assessments of migraine management, including the use of triptans, in Japan. Headache Care. 2004 1:115 121.
7. Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache. 2002 42:796 803.
8. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd ed. Cephalalgia. 2004 24 (suppl 1 1 160.
9. Tansey MJB, Pilgrim AJ, Martin PM. Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol. 1993 33:310 315.
10. Tepper SJ, Donnan GA, Dowson AJ et al A long-term study to maximise migraine relief with zolmitriptan. Curr Med Res Opin. 1999 15:254 271.
11. Pascual J, Munoz R, Leira R. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients. Cephalalgia. 2001 21:680 684.
12. Pascual J, Bussone G, Hernandez JF, et al Comparison of preference for rizatriptan 10 mg wafer versus sumatriptan 50 mg tablet in migraine. Eur Neurol. 2001 45:275 283.
13. Loder E, Brandes JL, Silberstein S, et al Preference comparison of rizatriptan ODT 10 mg and sumatriptan 50 mg tablet in migraine. Headache. 2001 41:745 753.
14. Dowson AJ, Bundy M, Salt R, Kilminster SG. Patient preference for different formulations of zolmitriptan: Results of two prospective studies. Headache Care. 2006 3:73 81.
15. Tfelt-Hansen P, Henry P, Mulder LJ, et al The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet. 1995 346:923 926.
16. Freitag FG, Cady R, DiSerio F, et al Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache. 2001 41:391 398.
17. Goldstein J, Silberstein SD, Saper JR, et al Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: Results from the ASSET trial. Headache. 2005 45:973 982.
18. Dodick DW. Triptan nonresponder studies: Implications for clinical practice. Headache. 2005 45:156 162.
19. Vollono C, Capuano A, Mei D, et al Multiple attack study on the available triptans in Italy versus placebo. Eur J Neurol. 2005 12:557 563.